Skip to main content
. 2012 Jan 3;21(8):1770–1781. doi: 10.1093/hmg/ddr610

Figure 6.

Figure 6.

Autophagy is inhibited at advanced stages of MSD liver pathology. (A) LC3 immunoblots on total liver homogenates from MSD (n= 3) and control mice (n= 3) at P15, 1 month and 3 months. Autophagosome accumulation is expressed as the fold change of the LC3-II/actin ratio compared with control; **P < 0.01, ***P < 0.005. (B) Levels of BECN-1 were measured in liver extracts from MSD (n= 3) and control mice (n= 3) at P15, 1 month and 3 months. The BECN-1/actin ratio is expressed as fold changes; **P < 0.01. (C) Becn1 mRNA levels were determined by real-time PCR in liver samples (n= 3) at 3 months.